首页    期刊浏览 2024年12月02日 星期一
登录注册

文章基本信息

  • 标题:O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
  • 本地全文:下载
  • 作者:Eunah Kim ; Jeong Gu Kang ; Min Jueng Kang
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:2020
  • 卷号:117
  • 期号:25
  • 页码:14259-14269
  • DOI:10.1073/pnas.1913469117
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:The Hippo pathway controls organ size and tissue homeostasis by regulating cell proliferation and apoptosis. The LATS-mediated negative feedback loop prevents excessive activation of the effectors YAP/TAZ, maintaining homeostasis of the Hippo pathway. YAP and TAZ are hyperactivated in various cancer cells which lead to tumor growth. Aberrantly increased O -GlcNAcylation has recently emerged as a cause of hyperactivation of YAP in cancer cells. However, the mechanism, which induces hyperactivation of TAZ and blocks LATS-mediated negative feedback, remains to be elucidated in cancer cells. This study found that in breast cancer cells, abnormally increased O -GlcNAcylation hyperactivates YAP/TAZ and inhibits LATS2, a direct negative regulator of YAP/TAZ. LATS2 is one of the newly identified O -GlcNAcylated components in the MST-LATS kinase cascade. Here, we found that O -GlcNAcylation at LATS2 Thr436 interrupted its interaction with the MOB1 adaptor protein, which connects MST to LATS2, leading to activation of YAP/TAZ by suppressing LATS2 kinase activity. LATS2 is a core component in the LATS-mediated negative feedback loop. Thus, this study suggests that LATS2 O -GlcNAcylation is deeply involved in tumor growth by playing a critical role in dysregulation of the Hippo pathway in cancer cells.
  • 关键词:Hippo pathway ; LATS2 ; MOB1 ; O -GlcNAcylation ; cancer
国家哲学社会科学文献中心版权所有